As previously reported, Redburn Atlantic initiated coverage of Domino’s Pizza (DPZ) with a Sell rating and $340 price target Domino’s faces the heaviest pressure from GLP-1 weight loss drug adoption, with high exposure to dinner occasions and lower-income consumers, the analyst tells investors in a research note. The firm says the company’s organic traffic remains weak, with carryout far outpacing delivery. With system sales growth challenged and consensus expectations still elevated, there is downside risk for Domino’s, contends Redburn.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DPZ:
- Domino’s Pizza initiated with a Sell at Redburn Atlantic
- Domino’s Pizza: Strategic Initiatives and Market Positioning Justify Buy Rating
- Coca-Cola Stock (KO) Remains a Berkshire Hathaway Favorite
- Domino’s Pizza: Balancing Growth Opportunities and Profitability Challenges Amidst Aggressive Market Environment
- Berkshire Hathaway exits positions in Citigroup, Nubank